Valuation: CARMAT

Market Cap 6.15M 7.1M 5.74M 5.25M 9.89M 677M 10.05M 67.36M 26.43M 339M 26.66M 26.08M 1.13B P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 59.25M 68.44M 55.38M 50.61M 95.37M 6.53B 96.87M 649M 255M 3.27B 257M 251M 10.88B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 31/08/2016
Director of Finance/CFO - 11/12/2018
Chief Tech/Sci/R&D Officer - 31/03/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 01/01/2017
Director/Board Member 79 19/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-.--% - - 7.08M
+0.48%+3.12%-8.03%+22.80% 133B
+0.61%-1.34%-17.57%-1.12% 12.57B
-0.18%+6.30%+108.32%+143.69% 10.7B
+0.30%-0.35%-42.48%-67.21% 4.72B
-0.79%+3.51%-24.77%+37.61% 2.68B
+0.55%-7.13%-25.19%-75.47% 1.73B
+0.98%+1.30%-14.30%-12.41% 1.7B
+0.69%-2.02%-33.31%-31.58% 1.67B
Average +0.25%+202.53%-7.17%+2.04% 21.05B
Weighted average by Cap. +0.51%+360.97%-3.07%+24.50%

Financials

2023 2024
Net sales 3.84M 4.43M 3.59M 3.28M 6.18M 423M 6.27M 42.06M 16.5M 211M 16.64M 16.28M 704M 7.34M 8.48M 6.86M 6.27M 11.82M 809M 12.01M 80.5M 31.59M 405M 31.85M 31.16M 1.35B
Net income -53.87M -62.23M -50.35M -46.02M -86.72M -5.93B -88.07M -590M -232M -2.97B -234M -229M -9.89B -51.4M -59.37M -48.04M -43.91M -82.74M -5.66B -84.03M -563M -221M -2.83B -223M -218M -9.43B
Net Debt 49.64M 57.34M 46.39M 42.4M 79.9M 5.47B 81.15M 544M 213M 2.74B 215M 211M 9.11B 53.1M 61.34M 49.63M 45.36M 85.48M 5.85B 86.82M 582M 228M 2.93B 230M 225M 9.75B
Logo CARMAT
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
-